Bio Diagnostics Business for Sale in Amman, Jordan
Established bio-diagnostics manufacturing business for sale with FDA/CE-certified production and 63 staff.
This transaction has concluded.
Premium Plan
| Established | 20-30 year(s) |
| Employees | 50 - 100 |
| Legal Entity | Sole Proprietorship/Sole Trader |
| Reported Sales | USD 4.6 million |
| Run Rate Sales | USD 4.6 million |
| EBITDA Margin | 9 % |
| Industries | Bio Diagnostics |
| Locations | Amman |
| Local Time | 10:23 AM Asia / Amman |
| Listed By | Business Owner / Director |
| Status | Active |
Full Sale
Asking Price:
USD
5 million
(Native Currency: USD 5,000,000)
Reason: Looking to sell the business due to old age.
We consider this a fair valuation based on the brand an...
View More
Includes physical assets worth
USD
1 million
Interested to connect with advisors
Documents
One Page Investor Summary
(174.0 KB)
Group Profile
(4.2 MB)
Domain-Verification.pdf
(213.9 KB)
Company Registration Certificate.
(2.1 MB)
Business Overview
- Company: 25-year-old bio-diagnostics manufacturer based in Amman, Jordan, specializing in in vitro diagnostic reagents and medical lab reagent kits.
- Workforce & scale: 63 employees operating US FDA- and CE-certified production and quality-control facilities.
- Product line: Reagents and complete diagnostic kits used to measure analytes in human blood, urine, and stool for clinical chemistry and medical laboratories.
- Production capacity: Able to produce 6,000 vials/day or ~1,000 kits/day, nominally ~24,000 kits/month at regular shifts; with overtime reaches ~30,000–35,000 kits/month.
- Market coverage: Export-focused business selling to ~90 countries via dealer network; active dealers in 70+ countries across the USA, LATAM, Europe (strong in Germany and other EU markets), MENA (notably KSA), West Asia, Southeast Asia, Africa, and the Americas.
- Customer profile: Primary customers are small-to-medium medical labs and diagnostic centers that consume 50–60% of the company’s routine reagent portfolio. Dealers/distributors serve larger regional purchasing and logistics.
- Competitive strengths: Regulatory certifications (USFDA, CE), long industry track record, broad geographic distribution, and capacity to scale production to meet rising lab reagent demand.
- Sales channels & monetization: Revenue generated through wholesale sales to dealers, direct bulk orders from clinical labs, and repeat sales of consumable reagents and diagnostic kits (recurring revenue from per-test consumables).
- Monthly revenue depends on the number and size of orders, not on the number of employees.
- Workforce & scale: 63 employees operating US FDA- and CE-certified production and quality-control facilities.
- Product line: Reagents and complete diagnostic kits used to measure analytes in human blood, urine, and stool for clinical chemistry and medical laboratories.
- Production capacity: Able to produce 6,000 vials/day or ~1,000 kits/day, nominally ~24,000 kits/month at regular shifts; with overtime reaches ~30,000–35,000 kits/month.
- Market coverage: Export-focused business selling to ~90 countries via dealer network; active dealers in 70+ countries across the USA, LATAM, Europe (strong in Germany and other EU markets), MENA (notably KSA), West Asia, Southeast Asia, Africa, and the Americas.
- Customer profile: Primary customers are small-to-medium medical labs and diagnostic centers that consume 50–60% of the company’s routine reagent portfolio. Dealers/distributors serve larger regional purchasing and logistics.
- Competitive strengths: Regulatory certifications (USFDA, CE), long industry track record, broad geographic distribution, and capacity to scale production to meet rising lab reagent demand.
- Sales channels & monetization: Revenue generated through wholesale sales to dealers, direct bulk orders from clinical labs, and repeat sales of consumable reagents and diagnostic kits (recurring revenue from per-test consumables).
- Monthly revenue depends on the number and size of orders, not on the number of employees.
Products & Services Overview
Our best-selling products are medical lab reagent kits, used in clinical chemistry and medical laboratories to measure analytes in human blood, urine, and stool, which we supply to dealers.
Assets Overview
Tangible assets include building, equipment, stocks, and recipes, while intangible assets consist of business registration, trade certifications, brand, and contracts.
Facilities Overview
We operate from our own property in a Freezone, consisting of a two-floor building with 600 sqm per floor.
Capitalization Overview
The business is funded through its revenue and a 450K JOD revolving bank loan, with a single 100% owner. Additional debts of around 600K JOD.Debts will be cleared once payment is received from the buyer.
Recent Activity
-
Earlier than 15 daysDirector, Medical Equipment, Durg, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysBusiness Head, Bengaluru, Financial Consultant connected with the Business
-
Earlier than 15 daysManaging Director, Dubai, Financial Consultant connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
